Status:
COMPLETED
Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Prostate Hyperplasia
Eligibility:
MALE
50-80 years
Phase:
NA
Brief Summary
This is a prospective series of consecutive cases of patients undergoing iTind for the treatment of male LUTS.
Detailed Description
This is a prospective series of consecutive cases of patients undergoing iTind for the treatment of male LUTS.The procedure was carried out using perioperative antibiotic prophylaxis, according to the...
Eligibility Criteria
Inclusion
- Men aged between 50 - 80 years
- Clinically indicated for surgical treatment
- Prostate volume of 25 to 75 cc
Exclusion
- Patients with active urinary tract infection or in retention of urine
- Patients with bleeding disorder or on anti-coagulation
- Patients with bladder pathology including bladder stone and bladder cancer
- Patients with urethral stricture
- Patients with neurogenic bladder and/or sphincter abnormalities
- Patients with previous nonpharmacological prostate treatment,
- Prostate cancer
- Fail to give informed consent
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2025
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT05440981
Start Date
September 1 2022
End Date
January 21 2025
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong